BR102020014545A2 - Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da obesidade e processo - Google Patents

Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da obesidade e processo Download PDF

Info

Publication number
BR102020014545A2
BR102020014545A2 BR102020014545-2A BR102020014545A BR102020014545A2 BR 102020014545 A2 BR102020014545 A2 BR 102020014545A2 BR 102020014545 A BR102020014545 A BR 102020014545A BR 102020014545 A2 BR102020014545 A2 BR 102020014545A2
Authority
BR
Brazil
Prior art keywords
implant
treatment
obesity
polymer
anorectic
Prior art date
Application number
BR102020014545-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Edson Luiz Peracchi
Original Assignee
Edson Luiz Peracchi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edson Luiz Peracchi filed Critical Edson Luiz Peracchi
Priority to BR102020014545-2A priority Critical patent/BR102020014545A2/pt
Priority to PCT/BR2020/050348 priority patent/WO2022011439A1/fr
Publication of BR102020014545A2 publication Critical patent/BR102020014545A2/pt

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR102020014545-2A 2020-07-16 2020-07-16 Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da obesidade e processo BR102020014545A2 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR102020014545-2A BR102020014545A2 (pt) 2020-07-16 2020-07-16 Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da obesidade e processo
PCT/BR2020/050348 WO2022011439A1 (fr) 2020-07-16 2020-08-31 Implant sous-cutané réabsorbable de longue durée à libération prolongée de substance pharmacologiquement active pré-concentrée en polymère pour le traitement de l'obésité et procédé

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102020014545-2A BR102020014545A2 (pt) 2020-07-16 2020-07-16 Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da obesidade e processo

Publications (1)

Publication Number Publication Date
BR102020014545A2 true BR102020014545A2 (pt) 2022-01-25

Family

ID=79555866

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102020014545-2A BR102020014545A2 (pt) 2020-07-16 2020-07-16 Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da obesidade e processo

Country Status (2)

Country Link
BR (1) BR102020014545A2 (fr)
WO (1) WO2022011439A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023225728A1 (fr) * 2022-05-27 2023-11-30 Luiz Peracchi Edson Implant sous-cutané réabsorbable de longue durée à libération prolongée de substance pharmacologiquement active pré-concentrée en polymère pour le traitement complémentaire de l'épilepsie, de douleurs chroniques et de l'anxiété, et méthode

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543405A (en) * 1993-10-22 1996-08-06 Keown; Wendy J. Composition and method for weight reduction and long term management of obesity
BRPI0708842A2 (pt) * 2006-03-28 2011-06-14 Gelesis Inc uso de materiais polimÉricos com outras substÂncias para aumento do desempenho
US20080234354A1 (en) * 2006-11-21 2008-09-25 Lippa Arnold S Methods And Compositions For Controlling Body Weight And Appetite
WO2009049105A2 (fr) * 2007-10-09 2009-04-16 Gelesis, Inc. Procédés d'induction du rassasiement

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023225728A1 (fr) * 2022-05-27 2023-11-30 Luiz Peracchi Edson Implant sous-cutané réabsorbable de longue durée à libération prolongée de substance pharmacologiquement active pré-concentrée en polymère pour le traitement complémentaire de l'épilepsie, de douleurs chroniques et de l'anxiété, et méthode

Also Published As

Publication number Publication date
WO2022011439A1 (fr) 2022-01-20

Similar Documents

Publication Publication Date Title
JP2023024704A (ja) 絶食条件下でのタシメルテオンの投与
US10869857B2 (en) Melatonin mini-tablets and method of manufacturing the same
Odin et al. Restless legs syndrome
JP2007502866A (ja) ナルメフェンの持続的放出のための移植可能ポリマー装置
BR102020014545A2 (pt) Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da obesidade e processo
JP5106809B2 (ja) ラクトフェリンを含有する医薬組成物ならびに加工食品
US20230255882A1 (en) Long-lasting resorbable subcutaneous implant with sustained release of pre-concentrated pharmacologically active substance in polymer for the treatment of parkinsons disease
CN106619558A (zh) 一种芬戈莫德胃溶型微丸片及其制备方法
KR20210097487A (ko) 후코이단을 포함하는 수면장애 예방, 개선 또는 치료용 조성물
EP4316464A1 (fr) Implant sous-cutané réabsorbable de longue durée à libération prolongée de substance pharmacologiquement active pré-concentrée en polymère pour le traitement de l'hypothyroïdie et procédé
BR102020025389A2 (pt) Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da dependência a nicotina e processo
BR102021014927A2 (pt) Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento do hipotireoidismo e processo
WO2022160022A1 (fr) Implant sous-cutané réabsorbable de longue durée à libération prolongée de substance pharmacologiquement active pré-concentrée en polymère pour le traitement du diabète de type 2 et procédé
US20230190641A1 (en) Long-lasting reabsorbable subcutaneous implant with sustained release of pre-concentrated pharmacologically active substance in polymer for the treatment of chronic adrenal insufficiency or hypocortisolism
RU2822514C1 (ru) Подкожный полимерный имплантат длительного действия с контролируемым высвобождением фармакологического преконцентрированного вещества для лечения эректильной дисфункции и доброкачественной гиперплазии предстательной железы
WO2023225728A1 (fr) Implant sous-cutané réabsorbable de longue durée à libération prolongée de substance pharmacologiquement active pré-concentrée en polymère pour le traitement complémentaire de l'épilepsie, de douleurs chroniques et de l'anxiété, et méthode
BR102021010270A2 (pt) Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da insuficiência adrenal crônica ou hipocortisolismo e processo de obtenção
WO2021237322A1 (fr) Implant sous-cutané réabsorbable de longue durée à libération prolongée de substance pharmacologiquement active pré-concentrée en polymère pour le traitement de la dysfonction érectile et de l'hyperplasie bénigne de la prostate
Zesiewicz et al. Medical treatment of motor and nonmotor features of Parkinson's disease
BR102021020738A2 (pt) Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para a manutenção de níveis adequados de dhea e dhea-s e processo
WO2023178250A1 (fr) Traitement de la sclérose tubéreuse avec du mirdametinib
CN113271929A (zh) 用于帮助睡眠的组合物及方法
TW202017565A (zh) 用於幫助睡眠之組合物及方法
WO2023178284A1 (fr) Traitement d'un gliome de bas grade avec du mirdametinib
CN117017961A (zh) 一种莱菔素及其组合物在制备抗疲劳产品中的应用

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]